Gamma Valerolactone Market Size(US$)

CAGR 2026-2032
2.8%
Market Size,2032
USD 731
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Gamma Valerolactone was estimated to be worth US$ 603 million in 2025 and is projected to reach US$ 731 million, growing at a CAGR of 2.8% from 2026 to 2032.
Gamma Valerolactone, commonly abbreviated as GVL, is a five-membered cyclic ester with the molecular formula C5H8O2 and CAS number 108-29-2. It is generally supplied as a colorless to pale-yellow liquid and is used in food flavors, fragrance formulations, industrial solvents, pharmaceutical and fine-chemical synthesis, polymer intermediates, lubricants, plasticizers and energy-related chemicals. GVL can be manufactured through the catalytic hydrogenation and cyclization of levulinic acid or levulinate esters using biomass-derived or petrochemical feedstocks. In 2025, global Gamma Valerolactone production reached approximately 26.5 K MT.
Gamma-valerolactone (GVL) is a renewable organic compound derived mainly from biomass sources such as lignocellulosic materials. It serves as a versatile green solvent, fuel additive, and intermediate in the production of chemicals, polymers, and pharmaceuticals. Its environmentally friendly profile, biodegradability, and relatively low toxicity make it attractive in applications where sustainable alternatives are sought to replace petroleum-based solvents and intermediates. GVL is also being explored as a platform molecule for producing biofuels and value-added chemicals, further enhancing its strategic importance in the shift toward a circular and bio-based economy.
The market for gamma-valerolactone is driven by the growing demand for green solvents in industrial processes, the need for sustainable fuel additives, and the rising interest in bio-based chemicals. Key end-use industries include chemicals, energy, pharmaceuticals, and agrochemicals, with research and development playing a significant role in expanding its commercial viability. However, challenges such as high production costs and limited large-scale manufacturing capacity currently restrict its widespread adoption. As advances in biomass conversion technologies mature and scale up, the market is expected to expand steadily, with strong opportunities in regions focusing on renewable energy and sustainable chemical production.
MARKET SEGMENTATION
REPORT SCOPE
This report provides a comprehensive view of the global market for Gamma Valerolactone, covering total sales volume, sales revenue, pricing, the market share and ranking of key companies, along with analyses by region & country, by Type, and by Application.
The Gamma Valerolactone market size, estimations, and forecasts are presented in terms of sales volume (Tons) and revenue ($ millions), with 2025 as the base year and historical and forecast data from 2021 to 2032. The report combines quantitative and qualitative analysis to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current marketplace, and make informed business decisions regarding Gamma Valerolactone.
CHAPTER OUTLINE
Chapter 1: Introduces the scope of the report and the global market size (value, volume, and price). It also summarizes market dynamics and Recent Developments; identifies key drivers and restraints; outlines challenges and risks for manufacturers; reviews relevant industry policies and U.S. tariff implications.
Chapter 2: Provides a detailed analysis of the Gamma Valerolactone manufacturers' competitive landscape—including pricing, sales and revenue shares, Recent Developments plans, and mergers and acquisitions (M&A).
Chapter 3: Analyzes market segmentation by Type, presenting the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 4: Analyzes market segmentation by Application, presenting the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 5: Presents Gamma Valerolactone sales and revenue at the regional level. It offers a quantitative assessment of market size and growth potential by region and summarizes market development, future prospects, addressable space, and country-level market size worldwide.
Chapter 6: Presents Gamma Valerolactone sales and revenue at the country level. It provides segmented data by Type and by Application for each country/region.
Chapter 7: Profiles key players, detailing the main companies' product sales, revenue, pricing, gross margin, product portfolios, Recent Developments, etc.
Chapter 8: Analyzes the industry value chain, including upstream suppliers and downstream applications/customers.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Gamma Valerolactone Product Introduction
1.2 Global Gamma Valerolactone Market Size Forecast
1.2.1 Global Gamma Valerolactone Sales Value (2021–2032)
1.2.2 Global Gamma Valerolactone Sales Volume (2021–2032)
1.2.3 Global Gamma Valerolactone Sales Price (2021–2032)
1.3 Gamma Valerolactone Market Trends & Drivers
1.3.1 Gamma Valerolactone Industry Trends
1.3.2 Gamma Valerolactone Market Drivers & Opportunities
1.3.3 Gamma Valerolactone Market Challenges
1.3.4 Gamma Valerolactone Market Restraints
1.3.5 Impact of U.S. Tariffs
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Gamma Valerolactone Players Revenue Ranking (2025)
2.2 Global Gamma Valerolactone Revenue by Company (2021–2026)
2.3 Global Gamma Valerolactone Sales Volume Ranking of Players (2025)
2.4 Global Gamma Valerolactone Sales Volume by Company (2021–2026)
2.5 Global Gamma Valerolactone Average Price by Company (2021–2026)
2.6 Key Manufacturers Gamma Valerolactone Manufacturing Base and Headquarters
2.7 Key Manufacturers Gamma Valerolactone Product Offerings
2.8 Key Manufacturers Start of Mass Production of Gamma Valerolactone
2.9 Gamma Valerolactone Market Competitive Analysis
2.9.1 Gamma Valerolactone Market Concentration Rate (2021–2026)
2.9.2 Global 5 and 10 Largest Manufacturers by Gamma Valerolactone Revenue in 2025
2.9.3 Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on Gamma Valerolactone revenue, 2025
2.10 Mergers & Acquisitions and Expansion
3 Segmentation Gamma Valerolactone Market Classification
3.1 Introduction by Type
3.1.1 Food Grade
3.1.2 Industrial Grade
3.1.3 Global Gamma Valerolactone Sales Value by Type
3.1.3.1 Global Gamma Valerolactone Sales Value by Type (2021 vs 2025 vs 2032)
3.1.3.2 Global Gamma Valerolactone Sales Value, by Type (2021–2032)
3.1.3.3 Global Gamma Valerolactone Sales Value, by Type (%), 2021–2032
3.1.4 Global Gamma Valerolactone Sales Volume by Type
3.1.4.1 Global Gamma Valerolactone Sales Volume by Type (2021 vs 2025 vs 2032)
3.1.4.2 Global Gamma Valerolactone Sales Volume, by Type (2021–2032)
3.1.4.3 Global Gamma Valerolactone Sales Volume, by Type (%), 2021–2032
3.1.5 Global Gamma Valerolactone Average Price by Type (2021–2032)
3.2 Introduction by Method
3.2.1 Chemical Method
3.2.2 Biological Method
3.2.3 Global Gamma Valerolactone Sales Value by Method
3.2.3.1 Global Gamma Valerolactone Sales Value by Method (2021 vs 2025 vs 2032)
3.2.3.2 Global Gamma Valerolactone Sales Value, by Method (2021–2032)
3.2.3.3 Global Gamma Valerolactone Sales Value, by Method (%), 2021–2032
3.2.4 Global Gamma Valerolactone Sales Volume by Method
3.2.4.1 Global Gamma Valerolactone Sales Volume by Method (2021 vs 2025 vs 2032)
3.2.4.2 Global Gamma Valerolactone Sales Volume, by Method (2021–2032)
3.2.4.3 Global Gamma Valerolactone Sales Volume, by Method (%), 2021–2032
3.2.5 Global Gamma Valerolactone Average Price by Method (2021–2032)
3.3 Introduction by Channel
3.3.1 Direct Selling
3.3.2 Distribution
3.3.3 Global Gamma Valerolactone Sales Value by Channel
3.3.3.1 Global Gamma Valerolactone Sales Value by Channel (2021 vs 2025 vs 2032)
3.3.3.2 Global Gamma Valerolactone Sales Value, by Channel (2021–2032)
3.3.3.3 Global Gamma Valerolactone Sales Value, by Channel (%), 2021–2032
3.3.4 Global Gamma Valerolactone Sales Volume by Channel
3.3.4.1 Global Gamma Valerolactone Sales Volume by Channel (2021 vs 2025 vs 2032)
3.3.4.2 Global Gamma Valerolactone Sales Volume, by Channel (2021–2032)
3.3.4.3 Global Gamma Valerolactone Sales Volume, by Channel (%), 2021–2032
3.3.5 Global Gamma Valerolactone Average Price by Channel (2021–2032)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Food Flavors
4.1.2 Solvent
4.1.3 Monomer Intermediate
4.1.4 Others
4.2 Global Gamma Valerolactone Sales Value by Application
4.2.1 Global Gamma Valerolactone Sales Value by Application (2021 vs 2025 vs 2032)
4.2.2 Global Gamma Valerolactone Sales Value, by Application (2021–2032)
4.2.3 Global Gamma Valerolactone Sales Value, by Application (%), 2021–2032
4.3 Global Gamma Valerolactone Sales Volume by Application
4.3.1 Global Gamma Valerolactone Sales Volume by Application (2021 vs 2025 vs 2032)
4.3.2 Global Gamma Valerolactone Sales Volume, by Application (2021–2032)
4.3.3 Global Gamma Valerolactone Sales Volume, by Application (%), 2021–2032
4.4 Global Gamma Valerolactone Average Price by Application (2021–2032)
5 Segmentation by Region
5.1 Global Gamma Valerolactone Sales Value by Region
5.1.1 Global Gamma Valerolactone Sales Value by Region: 2021 vs 2025 vs 2032
5.1.2 Global Gamma Valerolactone Sales Value by Region (2021–2026)
5.1.3 Global Gamma Valerolactone Sales Value by Region (2027–2032)
5.1.4 Global Gamma Valerolactone Sales Value by Region (%), 2021–2032
5.2 Global Gamma Valerolactone Sales Volume by Region
5.2.1 Global Gamma Valerolactone Sales Volume by Region: 2021 vs 2025 vs 2032
5.2.2 Global Gamma Valerolactone Sales Volume by Region (2021–2026)
5.2.3 Global Gamma Valerolactone Sales Volume by Region (2027–2032)
5.2.4 Global Gamma Valerolactone Sales Volume by Region (%), 2021–2032
5.3 Global Gamma Valerolactone Average Price by Region (2021–2032)
5.4 North America
5.4.1 North America Gamma Valerolactone Sales Value, 2021–2032
5.4.2 North America Gamma Valerolactone Sales Value by Country (%), 2025 vs 2032
5.5 Europe
5.5.1 Europe Gamma Valerolactone Sales Value, 2021–2032
5.5.2 Europe Gamma Valerolactone Sales Value by Country (%), 2025 vs 2032
5.6 Asia Pacific
5.6.1 Asia Pacific Gamma Valerolactone Sales Value, 2021–2032
5.6.2 Asia Pacific Gamma Valerolactone Sales Value by Region (%), 2025 vs 2032
5.7 South America
5.7.1 South America Gamma Valerolactone Sales Value, 2021–2032
5.7.2 South America Gamma Valerolactone Sales Value by Country (%), 2025 vs 2032
5.8 Middle East & Africa
5.8.1 Middle East & Africa Gamma Valerolactone Sales Value, 2021–2032
5.8.2 Middle East & Africa Gamma Valerolactone Sales Value by Country (%), 2025 vs 2032
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Gamma Valerolactone Sales Value Growth Trends, 2021 vs 2025 vs 2032
6.2 Key Countries/Regions Gamma Valerolactone Sales Value and Sales Volume
6.2.1 Key Countries/Regions Gamma Valerolactone Sales Value, 2021–2032
6.2.2 Key Countries/Regions Gamma Valerolactone Sales Volume, 2021–2032
6.3 United States
6.3.1 United States Gamma Valerolactone Sales Value, 2021–2032
6.3.2 United States Gamma Valerolactone Sales Value by Type (%), 2025 vs 2032
6.3.3 United States Gamma Valerolactone Sales Value by Application, 2025 vs 2032
6.4 Europe
6.4.1 Europe Gamma Valerolactone Sales Value, 2021–2032
6.4.2 Europe Gamma Valerolactone Sales Value by Type (%), 2025 vs 2032
6.4.3 Europe Gamma Valerolactone Sales Value by Application, 2025 vs 2032
6.5 China
6.5.1 China Gamma Valerolactone Sales Value, 2021–2032
6.5.2 China Gamma Valerolactone Sales Value by Type (%), 2025 vs 2032
6.5.3 China Gamma Valerolactone Sales Value by Application, 2025 vs 2032
6.6 Japan
6.6.1 Japan Gamma Valerolactone Sales Value, 2021–2032
6.6.2 Japan Gamma Valerolactone Sales Value by Type (%), 2025 vs 2032
6.6.3 Japan Gamma Valerolactone Sales Value by Application, 2025 vs 2032
6.7 South Korea
6.7.1 South Korea Gamma Valerolactone Sales Value, 2021–2032
6.7.2 South Korea Gamma Valerolactone Sales Value by Type (%), 2025 vs 2032
6.7.3 South Korea Gamma Valerolactone Sales Value by Application, 2025 vs 2032
6.8 Southeast Asia
6.8.1 Southeast Asia Gamma Valerolactone Sales Value, 2021–2032
6.8.2 Southeast Asia Gamma Valerolactone Sales Value by Type (%), 2025 vs 2032
6.8.3 Southeast Asia Gamma Valerolactone Sales Value by Application, 2025 vs 2032
6.9 India
6.9.1 India Gamma Valerolactone Sales Value, 2021–2032
6.9.2 India Gamma Valerolactone Sales Value by Type (%), 2025 vs 2032
6.9.3 India Gamma Valerolactone Sales Value by Application, 2025 vs 2032
7 Company Profiles
7.1 Soda Aromatic
7.1.1 Soda Aromatic Company Information
7.1.2 Soda Aromatic Introduction and Business Overview
7.1.3 Soda Aromatic Gamma Valerolactone Sales, Revenue, Price and Gross Margin (2021–2026)
7.1.4 Soda Aromatic Gamma Valerolactone Product Offerings
7.1.5 Soda Aromatic Recent Developments
7.2 Anhui Hyea Aromas
7.2.1 Anhui Hyea Aromas Company Information
7.2.2 Anhui Hyea Aromas Introduction and Business Overview
7.2.3 Anhui Hyea Aromas Gamma Valerolactone Sales, Revenue, Price and Gross Margin (2021–2026)
7.2.4 Anhui Hyea Aromas Gamma Valerolactone Product Offerings
7.2.5 Anhui Hyea Aromas Recent Developments
7.3 LangFang Hawk T&D
7.3.1 LangFang Hawk T&D Company Information
7.3.2 LangFang Hawk T&D Introduction and Business Overview
7.3.3 LangFang Hawk T&D Gamma Valerolactone Sales, Revenue, Price and Gross Margin (2021–2026)
7.3.4 LangFang Hawk T&D Gamma Valerolactone Product Offerings
7.3.5 LangFang Hawk T&D Recent Developments
7.4 Chongqing Zoteq Aromachemical
7.4.1 Chongqing Zoteq Aromachemical Company Information
7.4.2 Chongqing Zoteq Aromachemical Introduction and Business Overview
7.4.3 Chongqing Zoteq Aromachemical Gamma Valerolactone Sales, Revenue, Price and Gross Margin (2021–2026)
7.4.4 Chongqing Zoteq Aromachemical Gamma Valerolactone Product Offerings
7.4.5 Chongqing Zoteq Aromachemical Recent Developments
7.5 Jiangsu Qingquan Chemical
7.5.1 Jiangsu Qingquan Chemical Company Information
7.5.2 Jiangsu Qingquan Chemical Introduction and Business Overview
7.5.3 Jiangsu Qingquan Chemical Gamma Valerolactone Sales, Revenue, Price and Gross Margin (2021–2026)
7.5.4 Jiangsu Qingquan Chemical Gamma Valerolactone Product Offerings
7.5.5 Jiangsu Qingquan Chemical Recent Developments
7.6 Juye Zhongyue Aroma
7.6.1 Juye Zhongyue Aroma Company Information
7.6.2 Juye Zhongyue Aroma Introduction and Business Overview
7.6.3 Juye Zhongyue Aroma Gamma Valerolactone Sales, Revenue, Price and Gross Margin (2021–2026)
7.6.4 Juye Zhongyue Aroma Gamma Valerolactone Product Offerings
7.6.5 Juye Zhongyue Aroma Recent Developments
7.7 Kunshan Baihua Biotechnology
7.7.1 Kunshan Baihua Biotechnology Company Information
7.7.2 Kunshan Baihua Biotechnology Introduction and Business Overview
7.7.3 Kunshan Baihua Biotechnology Gamma Valerolactone Sales, Revenue, Price and Gross Margin (2021–2026)
7.7.4 Kunshan Baihua Biotechnology Gamma Valerolactone Product Offerings
7.7.5 Kunshan Baihua Biotechnology Recent Developments
7.8 Inoue Perfumery MFG
7.8.1 Inoue Perfumery MFG Company Information
7.8.2 Inoue Perfumery MFG Introduction and Business Overview
7.8.3 Inoue Perfumery MFG Gamma Valerolactone Sales, Revenue, Price and Gross Margin (2021–2026)
7.8.4 Inoue Perfumery MFG Gamma Valerolactone Product Offerings
7.8.5 Inoue Perfumery MFG Recent Developments
8 Industry Chain Analysis
8.1 Gamma Valerolactone Industrial Chain
8.2 Gamma Valerolactone Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Key Suppliers of Raw Materials
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customer Analysis)
8.5 Sales Model and Sales Channelss
8.5.1 Gamma Valerolactone Sales Model
8.5.2 Sales Channels
8.5.3 Gamma Valerolactone Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
Gamma Valerolactone (CAS 108-29-2) is colorless liquid. It is one of the more common lactones. GVL is chiral but is usually used as the racemate. It can be used to produce food flavors, used as solvent for resins, monomer intermediate, lubricant, plasticizer and so on.
Published Date: 2024-04-17
Pages: 151
USD 5600.00
(Single User License)
The global market for Gamma Valerolactone was valued at US$ 509 million in the year 2024 and is projected to reach a revised size of US$ 651 million by 2031, growing at a CAGR of 1.3% during the forecast period.
Published Date: 2025-09-12
Pages: 94
USD 2900.00
(Single User License)
The global market for Gamma Valerolactone was estimated to be worth US$ 741 million in 2024 and is forecast to a readjusted size of US$ 725 million by 2031 with a CAGR of -0.3% during the forecast period 2025-2031.
Published Date: 2025-01-16
Pages: 95
USD 3950.00
(Single User License)
In 2024, the global market size of Gamma Valerolactone was estimated to be worth US$ 741 million and is forecast to reach approximately US$ 725 million by 2031 with a CAGR of -0.3% during the forecast period 2025-2031.
Published Date: 2025-03-28
Pages: 125
USD 5900.00
(Single User License)
The global Gamma Valerolactone market size was US$ 509 million in 2024 and is forecast to a readjusted size of US$ 651 million by 2031 with a CAGR of 1.3% during the forecast period 2025-2031.
Published Date: 2025-09-12
Pages: 78
USD 4250.00
(Single User License)
The global Gamma Valerolactone market is projected to grow from US$ 509 million in 2024 to US$ 651 million by 2031, at a CAGR of 1.3% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-09-12
Pages: 136
USD 4900.00
(Single User License)
The global market for Gamma Valerolactone was estimated to be worth US$ 509 million in 2024 and is forecast to a readjusted size of US$ 651 million by 2031 with a CAGR of 1.3% during the forecast period 2025-2031.
Published Date: 2025-10-15
Pages: 109
USD 3950.00
(Single User License)
The global Gamma Valerolactone market was valued at US$ 603 million in 2025 and is anticipated to reach US$ 731 million by 2032, at a CAGR of 2.8% from 2026 to 2032.
Published Date: 2026-08-07
Pages: 133
USD 2900.00
(Single User License)
The global Gamma Valerolactone market size was US$ 603 million in 2025 and is forecast to reach a readjusted size of US$ 731 million by 2032 with a CAGR of 2.8% during the forecast period 2026-2032.
Published Date: 2026-08-07
Pages: 128
USD 4250.00
(Single User License)
The global Gamma Valerolactone market is projected to grow from US$ 603 million in 2025 to US$ 731 million by 2032, at a CAGR of 2.8% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-08-07
Pages: 141
USD 4900.00
(Single User License)
Gamma Valerolactone (CAS 108-29-2) is colorless liquid. It is one of the more common lactones. GVL is chiral but is usually used as the racemate. It can be used to produce food flavors, used as solvent for resins, monomer intermediate, lubricant, plasticizer and so on.
Published: 2024-04-17
Pages: 151
The global market for Gamma Valerolactone was valued at US$ 509 million in the year 2024 and is projected to reach a revised size of US$ 651 million by 2031, growing at a CAGR of 1.3% during the forecast period.
Published: 2025-09-12
Pages: 94
The global market for Gamma Valerolactone was estimated to be worth US$ 741 million in 2024 and is forecast to a readjusted size of US$ 725 million by 2031 with a CAGR of -0.3% during the forecast period 2025-2031.
Published: 2025-01-16
Pages: 95
In 2024, the global market size of Gamma Valerolactone was estimated to be worth US$ 741 million and is forecast to reach approximately US$ 725 million by 2031 with a CAGR of -0.3% during the forecast period 2025-2031.
Published: 2025-03-28
Pages: 125
The global Gamma Valerolactone market size was US$ 509 million in 2024 and is forecast to a readjusted size of US$ 651 million by 2031 with a CAGR of 1.3% during the forecast period 2025-2031.
Published: 2025-09-12
Pages: 78
The global Gamma Valerolactone market is projected to grow from US$ 509 million in 2024 to US$ 651 million by 2031, at a CAGR of 1.3% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-09-12
Pages: 136
The global market for Gamma Valerolactone was estimated to be worth US$ 509 million in 2024 and is forecast to a readjusted size of US$ 651 million by 2031 with a CAGR of 1.3% during the forecast period 2025-2031.
Published: 2025-10-15
Pages: 109
The global Gamma Valerolactone market was valued at US$ 603 million in 2025 and is anticipated to reach US$ 731 million by 2032, at a CAGR of 2.8% from 2026 to 2032.
Published: 2026-08-07
Pages: 133
The global Gamma Valerolactone market size was US$ 603 million in 2025 and is forecast to reach a readjusted size of US$ 731 million by 2032 with a CAGR of 2.8% during the forecast period 2026-2032.
Published: 2026-08-07
Pages: 128
The global Gamma Valerolactone market is projected to grow from US$ 603 million in 2025 to US$ 731 million by 2032, at a CAGR of 2.8% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-08-07
Pages: 141
REPORT COVERAGE
DESCRIPTION
MARKET SEGMENTATION
REPORT SCOPE
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report